2m 2m 2m 2m 2m 2m 2m
SENSEONIC HLDGS (SENS)
NASDAQ
$6.91+$0.04 (+0.60%)
Price as of Jun 03, 2026 7:45 PM EDT- $354.5MMarket Cap
- -35.15%1-Year Change
- Medical DevicesIndustry
SENSEONIC HLDGS (SENS)
$6.91+$0.04 (+0.60%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 17.1M -23.98% | 22.5M +0.37% | 22.4M +36.62% | 16.4M +19.85% | |
Cost of Revenue | 19.5M -11.14% | 21.9M +13.68% | 19.3M +41.25% | 13.7M -5.68% | |
Gross Profit | 15.8M +2,857.41% | 533,000 -82.76% | 3.1M +13.39% | 2.7M +436.13% | |
Sales and Marketing Expense | 52.5M +53.39% | 34.2M +14.32% | 29.9M -5.35% | 31.6M +476.95% | |
Research and Development Expense | -31.6M -23.22% | -41.1M -15.61% | -48.8M +22.74% | -39.7M +45.93% | |
Depreciation and Amortization Expense | 1.5M +2.51% | 1.5M +15.51% | 1.3M +29.64% | 985,000 -20.50% | |
Total Operating Expenses | 19.5M -11.14% | 21.9M +13.68% | 19.3M +41.25% | 13.7M -5.68% | |
Operating Profit | -68.3M -8.69% | -74.8M -1.01% | -75.6M +10.17% | -68.6M +20.02% | |
Interest Income | 4.2M -6.75% | 4.5M -16.04% | 5.4M +193.97% | 1.8M +650.62% | |
Interest Expense | -305,000 -96.38% | -8.4M -24.06% | -11.1M -40.60% | -18.7M +11.86% | |
Interest Income and Expense and Net | 3.9M +198.93% | -3.9M -31.54% | -5.7M -65.95% | -16.9M +2.44% | |
Total Nonoperating Income and Expense | -776,000 -79.44% | -3.8M -124.81% | 15.2M -92.78% | 210.7M +185.92% | |
Income before Taxes | -68.3M -8.69% | -74.8M -1.01% | -75.6M +10.17% | -68.6M +20.02% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | 138,000 0.00% | 138,000 -91.62% | |
Net Income | -69.1M -12.09% | -78.6M +30.18% | -60.4M -142.49% | 142.1M +146.99% | |
Net Income from Continuing Operations Applicable to Common | -69.1M -12.09% | -78.6M +30.18% | -60.4M -142.49% | 142.1M +146.99% | |
Basic EPS and Net Income | -1.66 +1,283.33% | -0.12 +9.09% | -0.11 -136.67% | 0.30 +141.67% | |
Diluted EPS and Net Income | -1.66 +1,283.33% | -0.12 +9.09% | -0.11 0.00% | -0.11 -84.72% | |
Basic Weighted Average Shares | 41.7M -93.37% | 629.7M +10.87% | 568.0M +21.37% | 468.0M +10.80% | |
Diluted Weighted Average Shares | 41.7M -93.37% | 629.7M +10.87% | 568.0M -8.13% | 618.2M +46.38% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 40.2M -46.06% | 74.6M -1.47% | 75.7M +111.52% | 35.8M +6.97% | |
Short-Term Investments | 53.8M +59.41% | 33.7M 0.00% | 33.7M -68.82% | 108.2M +12.21% | |
Cash and Cash Equivalents and Short-Term Investments | 94.0M -13.21% | 108.3M -1.02% | 109.5M -24.00% | 144.0M +10.86% | |
Total Current Assets | 117.5M +28.54% | 91.4M -29.68% | 130.0M -19.34% | 161.2M +11.62% | |
Accumulated Depreciation | N/A N/A | N/A N/A | 2.5M +21.84% | 2.0M +33.20% | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | 1.2M +6.47% | 1.1M -14.98% | |
Total Long-Term Assets | N/A N/A | N/A N/A | 1.2M +6.47% | 1.1M -14.98% | |
Total Assets | 126.3M +25.72% | 100.4M -27.33% | 138.2M -22.21% | 177.7M -10.68% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 20.1M 0.00% | 20.1M +29.26% | 15.6M -15.81% | 18.5M +532.43% | |
Total Current Liabilities | 24.3M -37.33% | 38.8M +125.12% | 17.3M -45.17% | 31.5M +71.09% | |
Total Long-Term Debt | 35.6M +2.54% | 34.7M -15.76% | 41.2M -26.94% | 56.4M -5.71% | |
Total Long-Term Liabilities | 40.9M +0.70% | 40.6M +553.20% | 6.2M +131.09% | 2.7M +364.42% | |
Total Liabilities | 65.2M -17.79% | 79.3M +22.49% | 64.8M -54.58% | 142.6M -62.91% | |
Retained Earnings | -1.0B +7.29% | -947.9M +9.04% | -869.3M +7.47% | -808.9M -14.94% | |
Total Stockholders Equity | 61.0M +468.75% | -16.6M -146.25% | 35.8M +1,489.60% | -2.6M -98.61% | |
Total Shares Outstanding | 41.3M -93.07% | 595.4M +12.25% | 530.4M +10.58% | 479.6M +7.23% | |
Cash Flow | |||||
Cash from Operating Activities | -59.1M -2.21% | -60.5M -13.82% | -70.2M +5.81% | -66.3M +18.25% | |
Capital Expenditures | 1.1M -50.16% | 2.2M +539.71% | 350,000 +12.18% | 312,000 +48.57% | |
Cash from Investing Activities | -53.4M -262.68% | 32.8M -63.40% | 89.7M +233.73% | 26.9M +118.07% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 78.2M +191.42% | 26.8M +31.74% | 20.4M -51.23% | 41.8M -81.02% | |
Financials Ratio | |||||
Gross Margin | -14.11% -694.77% | 2.37% -82.82% | 13.81% -17.00% | 16.63% +380.47% | |
Operating Margin | -400.01% +20.11% | -333.05% -1.37% | -337.66% -19.36% | -418.74% +0.14% | |
Return on Assets | -60.97% -7.45% | -65.88% +72.30% | -38.24% -150.66% | 75.47% +129.30% | |
Return on Equity | -310.68% -61.98% | -817.17% +124.75% | -363.59% +140.63% | -151.10% -182.33% | |
Revenue Growth | -23.98% -6,647.38% | 0.37% -99.00% | 36.62% +84.50% | 19.85% -88.74% | |
Current Ratio | 4.83 +105.09% | 2.35 -68.76% | 7.53 +47.10% | 5.12 -34.76% | |
Cash Ratio | 1.65 -13.94% | 1.92 -56.23% | 4.39 +285.75% | 1.14 -37.48% | |
Debt-to-Equity Ratio | 0.91 +127.55% | -3.31 -308.87% | 1.59 +105.46% | -29.07 +8,498.46% | |
Debt-to-Assets Ratio | 0.44 -19.18% | 0.55 +32.91% | 0.41 -2.54% | 0.42 +33.68% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow